TheraRadar
Data updated: May 26, 2026

EPANED KIT (enalapril maleate)

Cardiovascular Approved 2013-08-13
2
Indications
--
Phase 3 Trials
12
Years on Market

Details

Status
Discontinued
First Approved
2013-08-13
Patent Cliff
2032

Pro Metrics

Patent cliff and revenue data

Unlock with Pro
Routes
ORAL
Dosage Forms
FOR SOLUTION

Companies

Active Ingredient: ENALAPRIL MALEATE

EPANED KIT Approval History

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
8 FDA actions from 2013 to 2017 · 1 indication expansions
Jul 2017 SUPPL
Label · Labeling
Mar 2017 SUPPL
Label · Labeling
Jan 2016 SUPPL
Label · Labeling

What EPANED KIT Treats

2 FDA approvals

Originally approved for its first indication in 2013 . Covers 2 distinct patient populations.

  • Other (2)
📋

Clinical Trial Registry

4 trials
Trial Sponsor ID Phase Status Title
NCT03466333 PICk-UP R04725 Ph 2 completed Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
NCT03667131 EEVA Ph 2 completed Enalapril Maleate on Arterial Stiffness in Rheumatoid Arthritis.
NCT01871740 CSPPT-CKD Ausa-CSPPT-CKD Ph 4 withdrawn CSPPT- Chronic Kidney Diseases Study
NCT00794885 CSPPT Ausa-CSPPT Ph 4 completed China Stroke Primary Prevention Trial
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

EPANED KIT FDA Label Details

View full patent landscape →
4 OB patents · 1 families · 15 international docs across 6 countries

EPANED KIT Patents & Exclusivity

Latest Patent: Nov 2032

Patents (4 active)

US8778366 Expires Nov 6, 2032
US9968553 Expires Nov 6, 2032
US8568747 Expires Nov 6, 2032
US9855214 Expires Nov 6, 2032
Source: FDA Orange Book

Pro Intelligence Preview

Deep insights for EPANED KIT

Revenue Insights

  • Quarterly revenue tracking
  • Historical trend analysis

Patent Timeline

  • Cliff: 2032
  • 12 active patents

Trial Analysis

  • Clinical trial tracking
  • Development stage analysis

Competitive Landscape

  • Competitor tracking
  • Same target/indication analysis
Unlock Full Intelligence

Full approval history • All patents • Revenue trends • Competitor analysis

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.